A Biweekly <scp>GLP</scp> ‐ <scp>1R</scp> Agonist Designed With Drug‐Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability

Wei Ding, Qing Liu, Qiong Luo, Xiaojun Yao, Xingxing Fan

Open source

DOI: 10.1111/dom.71304
Published: 2026-09-08
Container: Diabetes, Obesity and Metabolism
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/dom.71304,
  title = {A Biweekly
                    <scp>GLP</scp>
                    ‐
                    <scp>1R</scp>
                    Agonist Designed With Drug‐Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability},
  author = {Wei Ding and Qing Liu and Qiong Luo and Xiaojun Yao and Xingxing Fan},
  year = {2026},
  journal = {Diabetes, Obesity and Metabolism},
  doi = {10.1111/dom.71304},
  url = {https://doi.org/10.1111/dom.71304}
}

RIS

TY  - JOUR
TI  - A Biweekly
                    <scp>GLP</scp>
                    ‐
                    <scp>1R</scp>
                    Agonist Designed With Drug‐Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability
AU  - Wei Ding
AU  - Qing Liu
AU  - Qiong Luo
AU  - Xiaojun Yao
AU  - Xingxing Fan
PY  - 2026
JO  - Diabetes, Obesity and Metabolism
DO  - 10.1111/dom.71304
UR  - https://doi.org/10.1111/dom.71304
ER  -

APA

Ding, W., Liu, Q., Luo, Q., Yao, X., & Fan, X. (2026). A Biweekly <scp>GLP</scp> ‐ <scp>1R</scp> Agonist Designed With Drug‐Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71304

Source records

crossref · retrieved 2026-09-24T19:41:12.172Z